Literature DB >> 1328311

Incidentally detected renal cell carcinoma: role of ultrasonography.

M Porena1, G Vespasiani, P Rosi, E Costantini, G Virgili, E Mearini, F Micali.   

Abstract

The widespread use of modern diagnostic imaging techniques, especially computed tomography and sonography, has led to the detection of an increasing number of serendipitous renal neoplasms, with no signs nor symptoms related to the neoplastic renal disease. In the last 4 years, 54 consecutive patients (20 females and 34 males) with renal cell carcinoma were reviewed. In 26 patients (48.15 per cent) the diagnosis was made as an incidental finding by an abdominal ultrasound examination. Clear signs and symptoms related to the neoplastic disease were present in 28 cases (51.85 per cent). The pathologic type of each neoplasm was categorized, and each carcinoma was staged. In the patients not surgically treated, the stage was determined on the basis of the diagnostic imaging reports. The results of this study suggest that the incidentally detected tumors are of a significantly lower stage than the symptomatic tumors (Wilcoxon rank sum test: P less than 0.0073 and X2 test: P less than 0.013). Early detection of renal tumors may improve the prognosis and the overall survival of patients with renal cell carcinoma and allow one to plan radical or partial nephrectomy, since local extension has a considerable impact on the operative strategy. Our experience emphasizes the role of ultrasound in the increased early detection of renal cell carcinoma.

Entities:  

Mesh:

Year:  1992        PMID: 1328311     DOI: 10.1002/jcu.1870200606

Source DB:  PubMed          Journal:  J Clin Ultrasound        ISSN: 0091-2751            Impact factor:   0.910


  9 in total

Review 1.  Incidental findings found in "healthy" volunteers during imaging performed for research: current legal and ethical implications.

Authors:  T C Booth; A Jackson; J M Wardlaw; S A Taylor; A D Waldman
Journal:  Br J Radiol       Date:  2010-03-24       Impact factor: 3.039

2.  Prospective comparison of use of contrast-enhanced ultrasound and contrast-enhanced computed tomography in the Bosniak classification of complex renal cysts.

Authors:  Matthew Ragel; Anbu Nedumaran; Jolanta Makowska-Webb
Journal:  Ultrasound       Date:  2016-01-24

3.  Can renal oncocytoma be differentiated from its renal mimics? The utility of anti-mitochondrial, caveolin 1, CD63 and cytokeratin 14 antibodies in the differential diagnosis.

Authors:  Ozgur Mete; Isin Kilicaslan; Mine G Gulluoglu; Veli Uysal
Journal:  Virchows Arch       Date:  2005-08-17       Impact factor: 4.064

Review 4.  [Ultrasound in oncology: screening and staging].

Authors:  S Delorme
Journal:  Internist (Berl)       Date:  2012-03       Impact factor: 0.743

5.  Renal tumors and second primary pancreatic tumors: a relationship with clinical impact?

Authors:  Sascha A Müller; Sascha Pahernik; Ulf Hinz; David J Martin; Moritz N Wente; Thilo Hackert; Christine Leowardi; Axel Haferkamp; Markus W Büchler; Bruno M Schmied
Journal:  Patient Saf Surg       Date:  2012-08-08

6.  Changes in clinicopathological characteristics of renal cell carcinoma in the past 25 years: a single-center experience.

Authors:  Jin Bong Choi; Byung Il Yoon; Su Jin Kim; Hyuk Jin Cho; Sung-Hoo Hong; Yeong Jin Choi; Sae Woong Kim; Tae-Kon Hwang; Ji Youl Lee
Journal:  Korean J Urol       Date:  2011-02-21

Review 7.  Localized renal cell carcinoma.

Authors:  P Russo
Journal:  Curr Treat Options Oncol       Date:  2001-10

8.  Histopathological analysis of T1 renal cell carcinoma: Does presentation matter?

Authors:  Gaurav Gupta; Samiran Das Adhikary; Santosh Kumar; Ninan K Chacko; Nitin S Kekre; Ganesh Gopalakrishnan
Journal:  Indian J Urol       Date:  2008-10

9.  Frequency, incidence and survival outcomes of clear cell renal cell carcinoma in the United States from 1973 to 2014: A SEER-based analysis.

Authors:  Xiao Feng; Lina Zhang; Wenzhi Tu; Shundong Cang
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.